Skip to main content
SpringerLink
Log in

Urokinase-Catalyzed Plasminogen Activation at the Monocyte/Macrophage Cell Surface: A Localized and Regulated Proteolytic System

  • Chapter
Macrophage Biology and Activation

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 181))

Abstract

In the adult organism, monocytes and macrophages are among the few cell types that can migrate within and between body compartments. To do so, they must have the capacity to clear for themselves a path through the macromolecular barriers of basement membranes and other extracellular matrices. This requires the controlled and localized degradation of matrix proteins by extracellular proteases. Mononuclear phagocytes can produce a number of such enzymes, including collagenolytic, elastinolytic, and gelatinolytic hydrolases (Takemura and Werb 1984). Because they can, directly or indirectly, catalyze the degradation of most components of extracellular matrices, plasminogen activators (PAs) are thought to play a key role in the proteolytic events that accompany the migration of a wide variety of cell types, during ontogeny as well as in pathologic circumstances. Monocytes and macrophages can produce PAs, and the regulation of their PA-dependent proteolytic activity has been a focus of attention in recent years. The findings of a number of investigators converge to suggest that the expression of PA activity is a tightly controlled phenotypic property of human and murine mononuclear phagocytes, and that multiple mechanisms act concurrently to achieve the exquisitely focused and regulated generation of plasmin precisely where and when it is needed to allow cell migration in the context of inflammatory reactions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Antalis TM, Clark MA, Barnes T et al. (1988) Cloning and expression of a cDNA coding for a human monocyte-derived plasminogen activator inhibitor. Proc Natl Acad Sci USA 85: 985–989.

    PubMed  CAS  Google Scholar 

  • Appella E, Robinson EA, Ullrich SJ, Stoppelli MP, Corti A, Cassani G, Blasi F (1987) The receptor-binding sequence of urokinase: a biological function for the growth-factor module of proteases. J Biol Chem 262: 4437–4440.

    PubMed  CAS  Google Scholar 

  • Ã…stedt B, Hägerstrand I, Lecander I, (1986) Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemost 56: 63–65.

    PubMed  Google Scholar 

  • Bajpai A, Baker JB (1985) Cryptic urokinase binding sites on human foreskin fibroblasts. Biochem Biophys Res Commun 133: 475–482.

    PubMed  CAS  Google Scholar 

  • Baker JB, Low DA, Simmer RL, Cummingham DD (1980) Proteasenexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21: 37–45.

    PubMed  CAS  Google Scholar 

  • Barnathan ES, Kuo A, Van der Keyl H, McCrae, KR, Larsen GR, Cines DB (1988) Tissue-type plasminogen activator binding to human endothelial cells. J Biol Chem 263: 7792–7799.

    PubMed  CAS  Google Scholar 

  • Belin D, Vassalli, J-D, Combépine C, et al. (1985) Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem 148: 225–232.

    PubMed  CAS  Google Scholar 

  • Belin D, Wohlwend A, Schleuning W-D, Kruithof EKO, Vassalli J-D (1989) Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2. EMBO J 8: 3287–3294.

    PubMed  CAS  Google Scholar 

  • Blasi F, Vassalli J-D, Danø K (1987) Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol 104: 801–804.

    PubMed  CAS  Google Scholar 

  • Busso N, Belin D, Failly-Crépin C, Vassalli J-D (1986) Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). J Biol Chem 261: 9309–9315.

    PubMed  CAS  Google Scholar 

  • Canipari R, O’Connell ML, Meyer G, Strickland S (1987) Mouse ovarian granulosa cells produce urokinase-type plasminogen activator, whereas the corresponding rat cells produce tissue-type plasminogen activator. J Cell Biol 105: 977–981.

    PubMed  CAS  Google Scholar 

  • Carrell R, Travis J (1985) α1-Antitrypsin and the serpins: variation and countervariation. Trends Biochem Sci 10: 20–24.

    CAS  Google Scholar 

  • Carlson M, Taussig R, Kustu S, Botstein D (1983) The secreted form of invertase in Saccharomyces cerevisiae is synthesized from mRNA encoding a signal sequence. Mol Cell Biol 3: 439–447.

    PubMed  CAS  Google Scholar 

  • Chapman HA Jr, Stone OL (1985a) Characterization of macrophage-derived plasminogen activator inhibitor (similarities with placental urokinase inhibitor). Biochem J 230: 109–116.

    PubMed  CAS  Google Scholar 

  • Chapman HA Jr, Stone OL (1985b) A fibrinolytic inhibitor of human alveolar macrophages. Induction with endotoxin. Am Rev Respir Dis 132: 569–575.

    PubMed  CAS  Google Scholar 

  • Chapman HA Jr, Vavrin Z, Hibbs JB Jr, (1982) Macrophage fibrinolytic activity: identification of two pathways of plasmin formation by intact cells and of a plasminogen activator inhibitor. Cell 28: 653–662.

    PubMed  CAS  Google Scholar 

  • Chapman HA Jr, Stone OL, Vavrin Z (1984) Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J Clin Invest 73: 806–815.

    PubMed  CAS  Google Scholar 

  • Collart MA, Belin D, Vassalli J-D, De Kossodo S, Vassalli P (1986) Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1 and urokinase genes, which are controlled by short lived repressors. J Exp Med 164: 2113–2118.

    PubMed  CAS  Google Scholar 

  • Collart MA, Belin D, Vassalli J-D, Vassalli P (1987) Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. J Immunol 139: 949–955.

    PubMed  CAS  Google Scholar 

  • Cubellis MV, Nolli ML, Cassani G, Blasi F (1986) Binding of single-chain prourokinase to the urokinase receptor of human U937 cells. J Biol Chem 261: 15819–15822.

    PubMed  CAS  Google Scholar 

  • Cubellis MV, Andreasen P, Ragno P, Mayer M, Danø K, Blasi F (1989) Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc Natl Acad Sci USA 86: 4828–4832.

    PubMed  CAS  Google Scholar 

  • Danø K, Andreasen PA, Grèndahl-Hansen J, Kristensen P, Nielsen LS, Skriver L (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44: 139–266.

    PubMed  Google Scholar 

  • Ellis V, Scully MF, Kakkar VV (1989) Plasminogen activation initiated by single-chain urokinase-type plasminogen activator: potentiation by U937 cells. J Biol Chem 264: 285–2188.

    Google Scholar 

  • Estreicher A, Wohlwend A, Belin D, Schleuning W-D, Vassalli J-D (1989) Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem 264: 1180–1189.

    PubMed  CAS  Google Scholar 

  • Falcone DJ (1989) Heparin stimulation of plasminogen activator secretion by macrophage-like cell line RAW264.7: role of the scavenger receptor. J Cell Physiol 140: 219–226

    PubMed  CAS  Google Scholar 

  • Falcone DJ, Ferenc MJ (1988) Acetyl-LDL stimulates macrophage-dependent plasminogen activation and degradation of extracellular matrix. J Cell Physiol 135: 387–396.

    PubMed  CAS  Google Scholar 

  • Feinberg RF, Kao LC, Haimowitz JE, Queenan, JT Jr, Wun T-C, Strauss JF III, Kliman HJ (1989) Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocyto-chemical marker of invading trophoblasts. Lab Invest 61: 20–26.

    PubMed  CAS  Google Scholar 

  • Ganter U, Bauer J, Majello B, Gerok W, Ciliberto G (1989) Characterization of mononuclear-phagocyte terminal maturation by mRNA phenotyping using a set of cloned cDNA probes. Eur J Biochem 185: 291–296.

    PubMed  CAS  Google Scholar 

  • Genton C, Kruithof EKO, Schleuning W-D (1987) Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol 104: 705–712.

    PubMed  CAS  Google Scholar 

  • Gloor S, Odnik K, Guenther J, Nick H, Monard D (1986) A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47: 687–693.

    PubMed  CAS  Google Scholar 

  • Gold LI, Schwimmer R, Quigley JP (1989) Human plasma fibronectin as a substrate for human urokinase. Biochem J 262: 529–534.

    PubMed  CAS  Google Scholar 

  • Golder JP, Stephens RW (1983) Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators. Eur J Biochem 136: 517–522.

    PubMed  CAS  Google Scholar 

  • Gordon S, Cohn ZA (1978) Bacille Calmette-Guérin in the mouse. Regulation of macrophage plasminogen activator by T lymphocytes and specific antigen. J Exp Med 147: 1175–1188.

    PubMed  CAS  Google Scholar 

  • Gordon S, Unkeless JC, Cohn ZA (1974) Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis, evidence for a two-stage process. J Exp Med 140: 995–1010.

    PubMed  CAS  Google Scholar 

  • Grøndahl-Hansen J, Lund LR, Ralfkiaer E, Ottevanger V, Danø K (1988) Urokinase-and tissue-type plasminogen activators in keratinocytes during woud reepithelialization in vivo. J Invest Dermatol 90: 790–795.

    PubMed  Google Scholar 

  • Günzler WA, Steffens GJ, Otting F, Kim S-MA, Frankus E, Flohé L (1982) The primary structure of high molecular mass urokinase from human rine. The complete amino acid sequence of the A chain. Hoppe-Seyler’s Z. Physiol Chem 363: 1155–1165.

    Google Scholar 

  • Gyetko MR, Webb AC, Sitrin RG (1988) Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1α, 25-dihydroxyvitamin D3 and phorbol ester. J Immunol 141: 2693–2698.

    PubMed  CAS  Google Scholar 

  • Hajjar KA, Harpel PC, Jaffe EA, Nachman RL (1986) Binding of plasminogen to human endothelial cells. J Biol Chem 261: 11656–11662.

    PubMed  CAS  Google Scholar 

  • Hajjar KA, Hamel NM, Harpel PC, Nachman RL (1987) Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest 80: 1712–1719.

    PubMed  CAS  Google Scholar 

  • Hamilton JA, Vassalli JD, Reich E (1976) Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory sterioids. J Exp Med 144: 1689.

    PubMed  CAS  Google Scholar 

  • Hamilton JA, Stanley ER, Burgess AW, Shadduck AA (1980) Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol 103: 435–445.

    PubMed  CAS  Google Scholar 

  • Hart PH, Vitti GF, Burgess DR, Singleton DK, Hamilton JA (1989a) Human monocytes can produce tissue-type plasminogen activator. J Exp Med 169: 1509–1514.

    PubMed  CAS  Google Scholar 

  • Hart PH, Burgess DR, Vitti GF, Hamilton JA (1989b) Interleukin-4 stimulates human monocytes to produce tissue-type plasminogen activator. Blood 74: 1222–1225.

    PubMed  CAS  Google Scholar 

  • Hashimoto K, Wun TC, Baird J, Lazarus GS, Jensen PJ (1989) Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol 92: 310–314.

    PubMed  CAS  Google Scholar 

  • Hébert CA, Baker JB (1988) Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin. J Cell Biol 106: 1241–1247.

    PubMed  Google Scholar 

  • Holmberg L, Lecander I, Persson B, Astedt B (1978) An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta 544: 128.

    PubMed  CAS  Google Scholar 

  • Hoylaerts M, Rijken DC, Lijnen HR, Collen D (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 257: 2912–2919.

    PubMed  CAS  Google Scholar 

  • Huarte J, Belin D, Bosco A-P, Sappino A-P, Vassalli J-D (1987) Plasminogen activator and mouse supermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface. J Cell Biol 104: 1281–1289.

    PubMed  CAS  Google Scholar 

  • Huber R, Carrell RW, (1989) Implications of the three-dimensional structure of α1-antitrypsin for structure and function of serpins. Biochemistry 28: 8951–8966.

    PubMed  CAS  Google Scholar 

  • Hume DA, Gordon S (1984) The correlation between plasminogen activator activity and thymidine incorporation in mouse bone marrow-derived macrophages. Exp Cell Res 150: 347–355.

    PubMed  CAS  Google Scholar 

  • Ichinose A, Fujikawa K, Suyama T (1986) The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. J Biol Chem 261: 3486–3489.

    PubMed  CAS  Google Scholar 

  • Kawano T, Morimoto K, Uemura Y (1968) Urokinase inhibitor in human placenta. Nature 217: 253–255.

    PubMed  CAS  Google Scholar 

  • Kirchheimer JC, Remold HG (1989) Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors. Blood 74: 1396–1402.

    PubMed  CAS  Google Scholar 

  • Kirchheimer JC, Nong Y-H, Remold HG (1988) IFN-γ, tumor necrosis factor-α, and urokinase regulate the expression of urokinase receptors on human monocytes. J Immunol 141: 4229–4234.

    PubMed  CAS  Google Scholar 

  • Klimetzek V, Sorg C (1977) Lymphokine-induced secretion of plasminogen activator by murine macrophages. Eur J Immunol 7: 185–187.

    PubMed  CAS  Google Scholar 

  • Klimetzek V, Sorg C (1979) The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages. Eur J Immunol 9: 613–619.

    PubMed  CAS  Google Scholar 

  • Kopitar M, Rozman B, Babnik J, Turk V, Mullins DE, Wun T-C (1985) Human leucocyte urokinase inhibitor. Purification, characterization and comparative studies against different plasminogen activators. Thromb Haemost 54: 750.

    PubMed  CAS  Google Scholar 

  • Krishnamurti C, Wahl LM, Alving BM (1989) Stimulation of plasminogen activator inhibitor activity in human monocytes infected with dengue virus. Am J Trop Med Hyg 40: 102–107.

    PubMed  CAS  Google Scholar 

  • Kruithof EKO, Vassalli J-D, Schleuning W-D, Mettaliano RJ, Bachmann F (1986) Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem 261: 11207–11213.

    PubMed  CAS  Google Scholar 

  • Kwiatkowski DJ, Mehl R, Yin HL (1988) Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol 106: 375–384.

    PubMed  CAS  Google Scholar 

  • Larsson LI, Skriver LS, Nielsen LS, Grondahl-Hansen J, Kristensen P, Danø K (1984) Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse. J Cell Biol 98: 894–903.

    PubMed  CAS  Google Scholar 

  • Lemaire G, Drapier JC, Petit JF (1983) Importance, localization, and functional properties of the cell-associated form of plasminogen activator in mouse peritoneal macrophages. Biochim Biophys Acta 755: 332–343.

    PubMed  CAS  Google Scholar 

  • Lison D, Knoops B, Collette C, Lauwerys R (1989) Comparison of the effects of auranofin and retinoic acid on plasminogen activator activity of peritoneal macrophages and Lewis lung carcinoma cells. Biochem Pharmacol 38: 2107–2112.

    PubMed  CAS  Google Scholar 

  • Loskutoff DJ, Van Mourik JA, Erickson LA, Lawrence D (1983) Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci USA 80: 2956–2960.

    PubMed  CAS  Google Scholar 

  • Lu H, Misrhahi MC, Krief P et al. (1988) Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cells. Biochem Biophys Res Commun 155: 418–422.

    PubMed  CAS  Google Scholar 

  • Lund LR, Georg B, Nielsen LS, Mayer M, Danø K, Andreasen PA (1988) Plasminogen activator inhibitor type 1: cell-specific and differentiation-induced expression and regulation in human cell lines; as determined by enzyme-linked immunosorbent assay. Mol Cell Endocrinol 60: 43–53.

    PubMed  CAS  Google Scholar 

  • Mignatti P, Robbins E, Rifkin DB (1986) Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 487–498.

    PubMed  CAS  Google Scholar 

  • Mignatti P, Tsuboi R, Robbins E, Rifkin DB (1989) In vitro angiogenesis on the human amniotic membrane: requirements for basic fibroblast growth factor-induced proteases. J Cell Biol 108: 671–682.

    PubMed  CAS  Google Scholar 

  • Miles LA, Plow EF (1987) Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost 58: 936–942.

    PubMed  CAS  Google Scholar 

  • Miles LA, Levin EG, Plescia J, Collen D, Plow EF (1988) Plasminogen receptors urokinase receptors, and their modulation on human endothelial cells. Blood 72: 628–635.

    PubMed  CAS  Google Scholar 

  • Miles LA, Dahlberg CM, Levin EG, Plow EF (1989) Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 28: 9337–9343.

    PubMed  CAS  Google Scholar 

  • Moscatelli D, Rifkin DB (1988) Membrane and matrix localization of proteinases: a common theme in tumor cell invasion and angiogenesis. Biochim Biophys Acta 948: 67–85.

    PubMed  CAS  Google Scholar 

  • Nielsen LS, Kellerman GM, Behrendt N, Picone R, Danø K, Blasi F (1988) A 55,000–60,000 Mr receptor protein for urokinase-type plasminogen activator: identification in human tumor cell lines and partial purification. J Biol Chem 263: 2358–2363.

    PubMed  CAS  Google Scholar 

  • Nogueira N, Gordon S, Cohn ZA (1977) Tryanosoma cruzi: the immunological induction of macrophage plasminogen activator requires thymus-derived lymphocytes. J Exp Med 146: 172–183.

    PubMed  CAS  Google Scholar 

  • Ossowski L (1988a) Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell 52: 321–328.

    PubMed  CAS  Google Scholar 

  • Ossowski L (1988b) In vivo invasion of modified chorioallantoic membrane by turner cells: the role of cell surface-bound urokinase. J Cell Biol 107: 2437–2445.

    PubMed  CAS  Google Scholar 

  • Pepper MS, Vassalli J-D, Montesano R, Orci L (1987) Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 105: 2535–2541.

    PubMed  CAS  Google Scholar 

  • Petersen LC, Lund LR, Nielsen LS, Danø K, Skriver L (1988) One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity. J Biol Chem 263: 11189–11195.

    PubMed  CAS  Google Scholar 

  • Picone R, Kajtaniak EL, Nielsen LS et al. (1989) Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. J Cell Biol 108: 693–702.

    PubMed  CAS  Google Scholar 

  • Plow EF, Freaney DE, Plescia J, Miles LA (1986) The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol 103: 2411–2420.

    PubMed  CAS  Google Scholar 

  • Pöllänen J, Hedman K, Nielsen LS, Danø K, Vaheri A (1988) Ultrastructural localization of plasma membrane-associated urokinse-type plasminogen activator at focal contacts. J Cell Biol 106: 87–95.

    PubMed  Google Scholar 

  • Potempa J, Dubin A, Watorek W, Travis J (1988) An elastase inhibitor from equine leukocyte cytosol belongs to the serpin superfamily. Further characterization and amino acid sequence of the reactive center. J Biol Chem 263: 7364–7369.

    PubMed  CAS  Google Scholar 

  • Reich E (1978) Activation of plasminogen; a general mechanism for producing localized extracellular proteolysis. In: Berlin RD, Herrman M, Lepow IH (eds) Molecular basis of biological degradative process. Academic New York, pp 155–169.

    Google Scholar 

  • Remold-O’Donnell E, Nixon JC, Rose RM (1989) Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils. J Exp Med 169: 1071–1086.

    CAS  Google Scholar 

  • Saksela O (1985) Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 823: 35–65.

    PubMed  CAS  Google Scholar 

  • Saksela O, Rifkin DB (1988) Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4: 93–126.

    PubMed  CAS  Google Scholar 

  • Saksela O, Hovi T, Vaheri A. (1985) Urikinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol 122: 125–132.

    PubMed  CAS  Google Scholar 

  • Salonen EM, Zitting A, Vaheri A (1984) Laminin interacts with plasminogen and its tissue-type plasminogen activator. FEBS Lett 172: 29–32.

    PubMed  CAS  Google Scholar 

  • Salonen EM, Saksela O, Vartio T, Vaheri A, Nielsen LS, Zeuthen J (1985) Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem 260: 12302–12307.

    PubMed  CAS  Google Scholar 

  • Sappino A-P, Huarte J, Belin D, Vassalli J-D (1989) Plasminogen activators in tissue remodeling invasion: mRNA localization in mouse ovaries and implanting embryos. J Cell Biol 109: 2471–2479.

    PubMed  CAS  Google Scholar 

  • Schleuning W-D, Medcalf RL, Hession C, Rothenbuhler R, Shaw A, Kruithof EKO (1987) Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol Cell Biol 7: 4564–4567.

    PubMed  CAS  Google Scholar 

  • Schnyder J, Baggiolini M. (1978) Role of phagocytosis in the activation of macrophages. J Exp Med 148: 1449–1457.

    PubMed  CAS  Google Scholar 

  • Schwartz BS, Bradshaw JD (1989) Differential regulation of tissue factor and plasminogen activator inhibitor by human mononuclear cells. Blood 74: 1644–1650.

    PubMed  CAS  Google Scholar 

  • Schwartz BS, Monroe MC, Levin EG (1988) Increased release of plasminogen activator inhibitor type 2 accompanies the human mononuclear cell tissue factor response to lipopolysaccharide. Blood 71: 734–741.

    PubMed  CAS  Google Scholar 

  • Shaw G, Kamen R (1986) A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659–667.

    PubMed  CAS  Google Scholar 

  • Singer II, Scott S, Hall GL, Limjuco G, Chin J, Schmidt JA (1988) lnterleukin-1β is localized in the cytoplasmic ground substance but is largely absent from the golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med 167: 389–407.

    PubMed  CAS  Google Scholar 

  • Solomon JA, Chou IN, Schroder EW, Black PH (1980) Evidence for membrane association of plasminogen activator activity in mouse macrophages. Biochem Biophys Res Commun 94: 480–486.

    PubMed  CAS  Google Scholar 

  • Spence AM, Sheppard PC, Davie JR et al. (1989) Regulation of a bifunctional mRNA results in synthesis of secreted and nuclear probasin. Proc Natl Acad Sci USA 86: 7843–7847.

    PubMed  CAS  Google Scholar 

  • Stephens R, Alitalo R, Tapiovaara H, Vaheri A (1988) Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors. Leuk Res 12: 419–422.

    PubMed  CAS  Google Scholar 

  • Stephens RW, Golder JP, Fayle DRH et al. (1985) Minactivin expression in human monocyte and macrophage populations. Blood 66: 333–337.

    PubMed  CAS  Google Scholar 

  • Stephens RW, Pöllännen J, Tapiovaara H et al. (1989) Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactions. J Cell Biol 108: 1987–1995.

    PubMed  CAS  Google Scholar 

  • Stoppelli MP, Corti A, Soffientini A, Cassani G, Blasi F, Assoian RK (1985) Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci USA 82: 4939–4943.

    PubMed  CAS  Google Scholar 

  • Takemura R, Werb Z (1984) Secretory products of macrophages and their physiological functions. Am J Physiol 246: C1–C9.

    PubMed  CAS  Google Scholar 

  • Tissot J-D, Schneider P, Hauert J, Ruegg M, Kruithof EKO, Bachmann F (1982) Isolation from plasma of a plasminogen activator indentical to urinary high molecular weight urokinase. J Clin Invest 70: 1320–1323.

    PubMed  CAS  Google Scholar 

  • Unkeless JC, Gordon S, Reich E (1974) Secretion of plasminogen activator by stimulated macrophages. J Exp Med 139: 834–850.

    PubMed  CAS  Google Scholar 

  • Vassalli J-D, Reich E (1977) Macrophage plasminogen activator: induction by products of activated lymphoid cells. J Exp Med 145: 429–437.

    PubMed  CAS  Google Scholar 

  • Vassalli J-D, Hamilton J, Reich E (1976) Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell 8: 271–281.

    PubMed  CAS  Google Scholar 

  • Vassalli J-D, Hamilton J, Reich E (1977) Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell 11: 695–705.

    PubMed  CAS  Google Scholar 

  • Vassalli J-D, Dayer J-M, Wohlwend A, Belin D (1984) Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med 159: 1653–1668.

    PubMed  CAS  Google Scholar 

  • Vassalli J-D, Baccino D, Belin D (1985) A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol 100: 86–92.

    PubMed  CAS  Google Scholar 

  • Vihko KK, Penttilä TL, Parvinen M, Belin D (1989) Regulation of urokinase-and tissue-type plasminogen activator gene expression in the rat seminiferous epithelium. Mol Endocrinol 3: 52–59.

    PubMed  CAS  Google Scholar 

  • Webb AC, Collins KL, Snydr SE et al. (1987) Human monocyte arg-serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitor. J Exp Med 166: 77–94.

    PubMed  CAS  Google Scholar 

  • Weitz JI, Cruickshank MK, Thong B, Leslie B, Levine MN, Ginsberg J, Eckhardt T (1988) Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen. J Clin Invest 82: 1700–1707.

    PubMed  CAS  Google Scholar 

  • Werb Z, Mainardi CL, Vater CA, Harris ED Jr (1977) Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 296: 1017–1023.

    PubMed  CAS  Google Scholar 

  • Wilson EL, Francis GE (1987) Differentiation-linked secretion of urokinase and tissue plasminogen activator by normal human hemopoietic cells. J Exp Med 165: 1609–1623.

    PubMed  CAS  Google Scholar 

  • Wilson EL, Jacobs P, Dowdle EB (1983) The secretion of plasminogen activators by human myeloid leukemic cells in virtro. Blood 61: 568–574.

    PubMed  CAS  Google Scholar 

  • Wohlwend A, Belin D, Vassalli J-D (1987a) Plasminogen activator-specific inhibitors produced by human monocytes-macrophages. J Exp Med 165: 320–339.

    PubMed  CAS  Google Scholar 

  • Wohlwend A, Belin D, Vassalli J-D (1987b) Plasminogen activator-specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion. J Immunol 139: 1278–1284.

    PubMed  CAS  Google Scholar 

  • Wun T-C, Ossowski L, Reich E (1982a) A proenzyme form of human urokinase. J Biol Chem 257: 7262–7268.

    PubMed  CAS  Google Scholar 

  • Wun T-C, Schleuning W-D, Reich E (1982b) Isolation and characterization of urokinase from human plasma. J Biol Chem 257: 3276–3283.

    PubMed  CAS  Google Scholar 

  • Ye RD, Wun TC, Sadler JE (1987) cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placenta. J Biol Chem 262: 3718–3725.

    PubMed  CAS  Google Scholar 

  • Ye RD, Wun TC, Sadler JE (1988) Mammalian protein secretion without signal peptide removal. Biosynthesis of plasminogen activator inhibitor-2 in U-937 cells. J Biol Chem 263: 4869–4875.

    PubMed  CAS  Google Scholar 

  • Ye RD, Ahern SM, Le Beau MM, Lebo RV, Sadler JE (1989) Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J Biol Chem 264: 5495–5502.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Histology and Embryology, University of Geneva Medical School, CH-1211, Geneva 4, Switzerland

    J.-D. Vassalli & A. Wohlwend

  2. Department of Pathology, University of Geneva Medical School, CH-1211, Geneva 4, Switzerland

    D. Belin

Authors
  1. J.-D. Vassalli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Wohlwend
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Belin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Kansas Cancer Ctr., Kansas City, KA, 66160-7312, USA

    Stephen W. Russell (Wilkinson Distinguished Professor and Director) (Wilkinson Distinguished Professor and Director)

  2. Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford, OX1 3RE, UK

    Siamon Gordon

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Vassalli, JD., Wohlwend, A., Belin, D. (1992). Urokinase-Catalyzed Plasminogen Activation at the Monocyte/Macrophage Cell Surface: A Localized and Regulated Proteolytic System. In: Russell, S.W., Gordon, S. (eds) Macrophage Biology and Activation. Current Topics in Microbiology and Immunology, vol 181. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77377-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77377-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77379-2

  • Online ISBN: 978-3-642-77377-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation